Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent Thromboinflammation
Clinical trial NCT05371275 · WITHDRAWN
Trial details
- NCT number
- NCT05371275
- Sponsor
- biotx.ai GmbH
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-21
- Primary completion
- 2022-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.